Ingrid Ljuslinder

Umea, AC, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

FDG PET/MRI for evaluation of nodal mesorectal structures in rectal cancer: A matched comparison to histopathology.

FDG PET/MRI for evaluation of nodal mesorectal structures in rectal cancer: A matched comparison to histopathology.

Journal: European journal of radiology

Published: January 04, 2026

Differential distribution of immune checkpoints across molecular subtypes of colorectal cancer.

Differential distribution of immune checkpoints across molecular subtypes of colorectal cancer.

Journal: Oncoimmunology

Published: August 21, 2025

Tissue-resident microbiota impacts colorectal cancer progression and prognosis.

Tissue-resident microbiota impacts colorectal cancer progression and prognosis.

Journal: Nature communications

Published: August 11, 2025

Type IV collagen, carcinoembryonic antigen, osteopontin, and hepatocyte growth factor as biomarkers for liver metastatic colorectal cancer.

Type IV collagen, carcinoembryonic antigen, osteopontin, and hepatocyte growth factor as biomarkers for liver metastatic colorectal cancer.

Journal: The International journal of biological markers

Published: April 28, 2025

A population-based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management.

A population-based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: November 07, 2024

Stoma versus no stoma prior to long-course neoadjuvant therapy in rectal cancer.

Stoma versus no stoma prior to long-course neoadjuvant therapy in rectal cancer.

Journal: BJS open

Published: August 24, 2024

Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients.

Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients.

Journal: Journal of translational medicine

Published: July 02, 2024

Evaluation of MRI characterisation of histopathologically matched lymph nodes and other mesorectal nodal structures in rectal cancer.

Evaluation of MRI characterisation of histopathologically matched lymph nodes and other mesorectal nodal structures in rectal cancer.

Journal: European radiology

Published: June 25, 2024

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US).

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US).

Journal: EClinicalMedicine

Published: March 18, 2024

Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUM.

Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUM.

Journal: Annals of surgery

Published: February 29, 2024

Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.

Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.

Journal: British journal of cancer

Published: May 24, 2023

Prognostic genome and transcriptome signatures in colorectal cancers.

Prognostic genome and transcriptome signatures in colorectal cancers.

Journal: Nature

Published: April 24, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026